Tdap vaccine

The Tdap vaccine protects against tetanus, diphtheria, and pertussis (whooping cough), making it crucial for both individual health and community immunity. Studies indicate that maternal vaccination with Tdap during pregnancy can significantly boost newborn protection against whooping cough, a disease particularly dangerous to infants. Research also shows that adherence to Tdap vaccine guidelines has improved over time, especially when recommended during pregnancy. Additionally, the vaccine's safety in pregnant women is well-supported, and there’s growing recognition of the need for booster doses due to waning immunity and evolving strains of pertussis bacteria. Connections to maternal health, newborn protection, and vaccination schedules highlight its importance across different life stages. While evidence supports Tdap’s benefits, more research could provide deeper insights into long-term effects and optimal dosing strategies.

Sources

• Maternal Vaccination and Vaccine Hesitancy. (PMID:36841594)
• Association of Tdap vaccine guidelines with vaccine uptake during pregnancy. (PMID:34280239)
• DTaP-IPV-HB-Hib vaccine (Hexaxim): an update 10 years after first licensure. (PMID:37936265)
• Vaccines - safety in pregnancy. (PMID:33773923)
• Pertussis in India: Vaccine-driven evolution, waning immunity, and the urgent need for Tdap boosters. (PMID:40221094)
• Pertussis: Common Questions and Answers. (PMID:34383446)

_Worker-drafted node, Hermes writer enrichment, pending editorial review._